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Introduction {#sec1}
============

The identification of conditions that allows for the *in vitro* differentiation of embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC) toward desired cell lineages have emerged as revolutionary new strategies for the development of cell-based replacement therapies. However, despite significant progress over the past few years, protocols for the induction of these pluripotent stem cells to differentiate into rare cell types, such as the pancreatic islet cells producing hormones like insulin and glucagon, remain relatively inefficient, often leading to heterogeneous cell preparations comprising unwanted cell types that may pose risks of teratoma development following transplantation ([@bib45], [@bib27], [@bib11]).

To date, the majority of protocols for the *in vitro*-directed differentiation of stem cells toward the islet cell lineage have focused on the administration of select growth factors and signaling molecules at defined time points that elicit the activation or inhibition of signaling pathways originally discovered to regulate islet cell development in animal models ([@bib42]). In these efforts, one aspect that remains relatively unexplored at the molecular level is the possible role of direct cell-to-cell communication, a mechanism known to regulate cell fate commitment and tissue morphogenesis during development ([@bib5], [@bib46], [@bib29], [@bib17], [@bib43], [@bib51]). Among proteins that have been shown to participate in these processes of cell communication, connexins (Cxs) are of special interest as they represent the building blocks of gap junction (GJ) channels, mediating the intercellular exchange of signaling molecules such as microRNAs, cations and anions, cyclic nucleotides, as well as small peptides and interfering RNAs ([@bib15], [@bib44]; [@bib49], [@bib12], [@bib4], [@bib30], [@bib22], [@bib23]). These channels have been shown to be indispensable for the proper growth, differentiation, and functional maturation of many cell types, both during embryonic development and in postnatal life ([@bib29]). Among Cxs known to participate to the biology of pancreatic cell lineages, Cx43 is of particular interest as it is expressed in the developing pancreas where, together with Cx36, it gets progressively restricted to the endocrine cell lineage ([@bib38]), and is required for the control of secretory function and survival ([@bib39], [@bib26], [@bib1], [@bib2], [@bib33], [@bib28]). Interestingly, Cx43 has also been found to be involved in the maintenance of stem cell pluripotency ([@bib8]), and in the regulation of the cell cycle during tissue development and regeneration ([@bib18]). Of further interest are studies demonstrating that interference with Cxs\' expression or function results in significant alterations of cell fate development, survival, and differentiated functions ([@bib40], [@bib33], [@bib47], [@bib10]).

In this study, building on the notion that the function of GJ channels is dependent on their gating status, we tested a simple gain-of-function approach that promotes the activation or opening of GJ channels composed of Cx43. The approach consisted in treating ESCs undergoing controlled differentiation toward pancreatic cell lineages with the AAP10-activating peptide, reported to promote Cx43 GJ channel opening ([@bib48], [@bib6], [@bib21], [@bib10]). The results of these experiments demonstrate that activation of Cx43 GJ channels in ESCs significantly enhances the expression of definitive endoderm (DE) markers FoxA2 and Sox17, which in turn results in a more efficient derivation of DE and primitive gut tube (PGT) cells, as well as more prominent numbers of posterior foregut (PF), pancreatic progenitors (PP), and pancreatic endocrine progenitors (EP). Collectively, these results provide evidence for the functional involvement of GJ channels in the differentiation of ESCs into pancreatic cell lineages.

Results {#sec2}
=======

In a first series of experiments, to determine the expression profile of Cx43 in ESCs under conditions that favor spontaneous differentiation, we followed a protocol of suspension culture to generate embryoid bodies (EBs). EB formation recapitulates the early steps of tissue development by yielding lineages with morphological features of ectoderm (ED), mesoderm (MD), and DE ([@bib19], [@bib53], [@bib25]). These experiments revealed that DE cells, identified by the co-expression of E-cadherin, Sox9, and Sox17 ([Figures 1](#fig1){ref-type="fig"}A--1D, dotted region), exhibited the strongest Cx43-specific immunoreactivity and showed the largest Cx43^+^ junctional plaques ([Figures 1](#fig1){ref-type="fig"}E and 1F, arrowheads). ED cells, as defined by the co-expression of E-cadherin and Sox9 ([Figures 1](#fig1){ref-type="fig"}A and 1B, arrowheads), also expressed detectable levels of Cx43 ([Figures 1](#fig1){ref-type="fig"}C and 1D, arrowheads). In contrast, MD cells, identified by the expression of vimentin and Sox9, and lack of E-cadherin, Sox17, and FoxA2, expressed the lowest levels of CX43 ([Figure 1](#fig1){ref-type="fig"}D, blue arrows). From these studies we conclude that during the specification of the three germ layers, the expression of Cx43 segregates with primarily DE and ED cells, with the most prominent levels being expressed in DE cells.Figure 1Cx43 Is Preferentially Expressed in Ectoderm and Definitive Endoderm (DE) Developing from hESC *In Vitro*(A) Sections of H1 embryoid bodies (EBs) immunostained for E-cadherin (red), FoxA2 (green), and Sox9 (blue), showing areas of E-cadh^+^FoxA2^+^Sox9^+^ definitive endoderm (dotted region), Ecad^+^FoxA2^neg^Sox9^+^ ectoderm (arrowheads), and Ecad^neg^ mesoderm.(B) Monochromatic image from the microscopic field shown in (A) allows better identification of E-cadherin^+^ cells.(C) Serial sections from the same EB preparations immunostained for Cx43 (red), Sox17 (green), and vimentin (blue) reveal that Cx43 is expressed at low levels in ectoderm (arrowheads) and at high levels in Sox17^+^vimentin^neg^ definitive endoderm cells in the same dotted region defined by the co-expression of E-cadherin, FoxA2, and Sox9 in (A).(D--F) (E and F) Higher magnification of definitive endoderm cells identified in (C) and (D). Note that immunoreactivity specific for Cx43 is very low in mesoderm cells identified by vimentin expression and lack of E-cadherin immunoreactivity (blue arrows). Images are representative of n = 8 experiments. Scale bars, 50 μm in (A--D) and 20 μm in (E and F).

We next investigated the expression profile of Cx43 in ESCs cultured under conditions that direct their differentiation toward the pancreatic cell lineages ([@bib55], [@bib56], [@bib57], [@bib58], [@bib37], [@bib34], [@bib41], [@bib42]) ([Figure 2](#fig2){ref-type="fig"}A). These studies uncovered a progressive upregulation of Cx43, both at the transcriptional ([Figure 2](#fig2){ref-type="fig"}B) and translational levels ([Figures 2](#fig2){ref-type="fig"}C and 2D), that peaked at the DE and PGT stages of ESC differentiation, followed by a sudden drop at the posterior foregut (PF) stage. In these experiments, treatment of human ESC (hESC) cultures after the DE stage with the AAP10 peptide, reported to increase Cx43 expression ([@bib9]), had no significant effects on the levels of this GJ protein ([Figures 2](#fig2){ref-type="fig"}C and 2D).Figure 2Expression Profiling of Cx43 in hESC Directed to Differentiate toward Pancreatic Cell Lineages(A) Schematic of stepwise protocol for the directed differentiation of hESC into pancreatic cell lineages.(B) Gene expression of Cx43 throughout all stages of hESC differentiation, as measured by qPCR. Data are presented as mean ± SD (n = 4). ∗∗p \< 0.01, ∗∗∗p \< 0.001. Expression of Cx43, although detected in undifferentiated hESC, progressively increases during early stages of differentiation into mesendoderm (ME), definitive endoderm (DE), and primitive gut tube (PGT), followed by a sudden decline after the specification of downstream cell lineages (i.e., posterior foregut \[PF\]).(C) Validation of Cx43 protein expression during hESC differentiation, in the presence or absence of AAP10 peptide added at post-DE stages as detected by western blot.(D) Densitometric analysis of protein bands shown in (C). Bars are mean ± SE of n = 3 experiments ∗∗p \< 0.01, ∗∗∗p \< 0.001.(E and F) (E) Flow cytometric dot plots of DE cells differentiated from H1 and (F) ELF1 hESC lines, as measured by the co-expression of E-cadherin and CXCR4. Knockdown of Cx43 by siRNA results in decreased yield of DE. Representative of n = 3.

Based on these results we hypothesized that Cx43 function is required for proper DE development. Accordingly, in parallel experiments we found that downregulation of Cx43 in two hESC lines, H1 and ELF1 ([@bib59]), by means of Cx43-specific small interfering RNAs (siRNAs) transfected just before the induction of DE differentiation, consistently decreased the yield of Ecad^+^/CXCR4^+^ DE cells, as measured by quantitative flow cytometry ([Figures 2](#fig2){ref-type="fig"}E and 2F, % mean ± SE of DE cell yield in siCx43 cultures = 25% ± 6% of control siRNA cultures; n = 3). Collectively, these experiments indicate that ESCs undergoing differentiation toward DE rely on the expression of Cx43.

Based on the notion that the function of a given Cx in a cell depends on the gating (opening) of the GJ channels that it forms, we next tested the ability of the AAP10 peptide to elicit GJ-mediated cell-to-cell communication in ESC cultures under conditions of directed differentiation toward pancreatic cell lineages ([@bib55], [@bib56], [@bib57], [@bib58], [@bib37], [@bib34], [@bib41], [@bib42]). The rationale for these experiments is based on the demonstration that this peptide has been previously reported to promote Cx43 phosphorylation and GJ channel opening ([@bib48], [@bib6], [@bib21], [@bib10]), thus providing us with a gain-of-function strategy to determine if a Cx43-mediated increase in cell-cell communication could impact ESC differentiation during early stages of DE induction. As a first step, we tested if the AAP10 peptide was in fact able to enhance cell-cell GJ-mediated communication in our ESC culture conditions. To this end, ESC cultures at the DE stage were supplemented with the AAP10 peptide, and GJ functionality (i.e., opening) was assessed by cell loading of carboxyfluorescein using a scrape-load assay ([@bib35]). These experiments revealed that in control cultures, carboxyfluorescein-loaded cells transferred the fluorescent dye to a few contacting cell layers over a period of 15 min ([Figures 3](#fig3){ref-type="fig"}A--3C and 3G). When compared with these controls, cell-cell communication in AAP10-treated cultures was enhanced by \~2 fold, as indicated by the rapid and progressive transfer of the dye from those carboxyfluorescein-loaded cells contacting the wound region to a large number of cells distant from the wound ([Figures 3](#fig3){ref-type="fig"}D--3G). In contrast, rhodamine dextran (70 kDa), a dye too large to be transferred through GJ channels, remains confined to the loaded cells at the edge of the wound. Pre-treatment of the cultures with the GJ inhibitor carbenoxolone ([@bib16]) effectively inhibited cell-cell communication in all cultures ([Figure 3](#fig3){ref-type="fig"}H). Collectively, these results demonstrate the efficacy and specificity of AAP10 treatment as a potent activator of GJ communication in differentiating ESCs.Figure 3Assessment of GJ Communication in hESC Using a Carboxyfluorescein Scrape-Loading Assay(A--F) H1 DE monolayers (day 3) were incubated with rhodamine dextran (Rhod DX) and carboxyfluorescein (CF) in the presence or absence of AAP10 (400 nM) and then scraped with a 10-μL pipette tip. After washings, cells at the wound edge (arrows) were imaged by light (DIC) and fluorescent microscopy at 5 (A and D) and 15 min (B, C, E, and F) post-dye loading. Representative of n = 3 independent experiments. Treatment of hESC cultures with the Cx43-activating peptide AAP10 significantly increases CF transfer, indicating enhanced GJ communication. Rhod DX, used as a control, remains confined to the loaded cells at the edge of the wound. Scale bars, 150 μm in (A--E) and 35 μm in (F).(G) Cumulative quantitative analysis of CF^+^ cells imaged as in (A--F). Bars are mean ± SE of CF^+^ cells counted in 40--50 random areas, on either sides of the wound and up to 200 μm from the wound\'s edge. ∗p \< 0.05, ∗∗p \< 0.01.(H) Imaging of hESC DE cultures pre-treated with carbenoxolone demonstrates effective blockade of CF transfer. Scale bar, 100 μm.

Building on these observations, we next conducted experiments of ESC differentiation in the presence or absence of the AAP10 peptide to determine the impact of Cx43-GJ channel activation on ESC developmental propensity to acquire a DE phenotype. In these studies, we observed that AAP10 treatment results in upregulation of both FoxA2 and Sox17 transcripts ([Figure 4](#fig4){ref-type="fig"}A). AAP10 induces a progressive increase of FoxA2-specific transcripts, from ME to DE and PGT stages, followed by a gradual decrease thereafter ([Figure 4](#fig4){ref-type="fig"}A, left panel). In contrast, the effect of GJ activation by this peptide on the induction of Sox17-specific transcripts occurs more rapidly (within 24 h) from the ME to the DE stage, followed by a rapid decrease at the PGT and subsequent stages of ESC differentiation ([Figure 4](#fig4){ref-type="fig"}A, right panel). These results were validated at the protein levels ([Figures 4](#fig4){ref-type="fig"}B, 4E, and 4F), indicating that activation of Cx43-GJ channels exerts a potent positive regulatory function on ESC differentiation toward DE and PGT lineages. As part of the same studies we also validated the effects of AAP10 on Cx43 phosphorylation that appears more prominent at the DE stage of ESC differentiation ([Figures 4](#fig4){ref-type="fig"}B and 4D). These effects coincided with a notable increase in Cx43-specific immunoreactivity in ESC cultures treated with AAP10 ([Figure 4](#fig4){ref-type="fig"}C), which appeared organized into larger GJ plaques in the presence of the peptide ([Figure 4](#fig4){ref-type="fig"}C, lower panels, insets, arrowheads). Last, quantitative flow cytometric analysis of DE cultures untreated or treated with AAP10 demonstrated that AAP10-containing cultures yield a higher number of DE cells, as defined by the co-expression of E-cadherin and CXCR4 ([Figures 4](#fig4){ref-type="fig"}G and 4H). Together, these results indicate that activation of Cx43-GJ channels during ESC differentiation fosters a more efficient development of DE cell lineages.Figure 4Induction of Definitive Endoderm Is Enhanced by the Cx43 Agonist AAP10 Peptide(A) qPCR analysis of FoxA2 and Sox17 gene expression in H1 cells throughout all stages of differentiation. Gene expression of these DE markers is increased at DE and PGT stages in cultures treated with AAP10 throughout the differentiation protocol (p \< 0.01), followed by a decline during subsequent stages. Bars are mean ± SE of n = 3--4 experiments (no peptide n = 4, AAP10 n = 3).(B) Western blot analysis of total CX43, phospho-Cx43, FoxA2, and SOX17 protein levels at DE, PGT, and PF stages expressed in cells differentiated in the absence or presence of AAP10 (representative of N = 3).(C) Immunostaining for Cx43 (red), FoxA2 (green), and Nanog (blue) shows a significant increase in GJ plaque sizes (insets, arrowheads) in H1 DE treated with the AAP10 peptide.(D--F) Cumulative densitometric analysis of the indicated protein-specific bands detected by western blot shown in (B). Bars are mean ± SD of n = 2--3 experiments. ∗p \< 0.05, ∗∗p \< 0.01, ∗∗∗p \< 0.001.(G) Fluorescence-activated cell sorting analysis of DE cells identified by E-cadherin and CXCR4 co-expression in control and AAP10-treated hESC cultures. Representative of n = 3 experiments.(H) Cumulative analysis of flow cytometric data as shown in (G), demonstrating increased yield of DE cells generated in the presence of AAP10. N = 4. ∗∗p \< 0.01.

Next, to determine if DE cells developing under AAP10 treatment are competent to proceed toward downstream lineages, such as posterior foregut (PF), PP, and EP, we conducted a detailed morphometric analysis for the expression of Pdx1, Nkx6.1, and Sox9, and enumerated cells expressing these markers at each stage of differentiation, in the presence or absence of AAP10. Based on the observed induction of a more efficient DE development when the function of Cx43-GJ channels is activated by AAP10 ([Figure 4](#fig4){ref-type="fig"}), we also tested if cell lineages developing downstream of DE and PGT, although expressing significantly lower levels of Cx43, could also benefit from the GJ-activating properties of this peptide. To test this possibility, ESC cultures were differentiated either under control conditions (no peptide treatment), in the presence of AAP10 up to the specification of DE (referred to as "AAP10 Stop @ DE"), or throughout the differentiation process (referred to as "AAP10 Throughout"). These studies revealed that, overall, the development of Pdx1+ progenitors is significantly increased by AAP10 treatment ([Figures 5](#fig5){ref-type="fig"}A--5C), although there was no statistical difference between conditions comparing the duration of the AAP10 treatment during the differentiation process (i.e., "AAP10 Stop @ DE" versus "AAP10 Throughout") ([Figure 5](#fig5){ref-type="fig"}C). Interestingly, we noted that the frequency of Sox9^+^Pdx1^+^ ([Figures 5](#fig5){ref-type="fig"}A and 5D) and Pdx1^+^Nkx6.1^+^ progenitors ([Figures 5](#fig5){ref-type="fig"}B and 5E) was also significantly increased by AAP10 treatment. These results indicate that DE cells produced under conditions that are permissive of Cx43 GJ function have a higher propensity to adopt a differentiation pathway toward PPs and PEs. Together, these studies demonstrate that mechanisms of cell-to-cell communication play an important role in the early specification of development of DE and pancreatic cell lineages from stem cell preparations. Hence, our results may have important implications for the refinement of *in vitro*-directed protocols of stem cells differentiation into pancreatic islet cells.Figure 5Activation of Cx43 GJ by AAP10 during Early Stages of ESC Differentiation Results in Greater Induction of Pdx1^+^Nkx6.1^+^ Progenitors(A and B) Immunostaining of ESC cultures at the end of the differentiation protocol (A) for Sox9 (red) and Pdx1 (green) and (B) for Nkx6.1 (red) and Pdx1 (green). Treatment with AAP10 was conducted either up to the DE stage (AAP10 Stop @ DE), or throughout the duration of the differentiation protocol (AAP10 Throughout).(C) Morphometric assessment of the frequency of Pdx1+ cells in the different culture conditions.(D and E) Percentage of (D) Sox9^+^Pdx1^+^ cells and (E) Pdx1^+^Nkx6.1^+^ cells in ESC cultures under control and AAP10 treatments. Images shown in (A) and (B) are representative of n = 3. Data presented in (C--E) were from n = 3 independent experiments. ∗p \< 0.05; ∗∗p \< 0.01; ∗∗∗p \< 0.001.

Discussion {#sec3}
==========

Knowledge gained from the field of developmental biology has played a pivotal role in the design of strategies that have driven our ability to direct the differentiation of stem cells into cell lineages of interest. Despite remarkable progress over the past two decades, a number of limitations remain to be addressed before pluripotent stem cells can be broadly used as a source for the design of cell-based replacement therapies for diseases such as type 1 and possibly type 2 diabetes ([@bib54], [@bib55], [@bib60], [@bib61], [@bib62], [@bib63]). These include the variability between different stem cell lines (both ESCs and iPSCs) with regard to their developmental propensity, or bias, toward one cell lineage versus another; the relative heterogeneity of their differentiated progeny following *in vitro*-directed differentiation; as well as the incomplete functional maturation that would make these cell preparations desirable for clinical applications. Hence, more recent efforts have been devoted to strategies that could minimize some of these concerns ([@bib58], [@bib57], [@bib37], [@bib64]).

In the present study we identified an important role of the GJ protein Cx43 as a positive regulator of DE cells from ESCs. We show that the functional activation of Cx43 GJ channels by the AAP10 peptide in ESCs under culture conditions that promote their differentiation results in a robust induction of genes such as FoxA2 and Sox17 ([Figure 4](#fig4){ref-type="fig"}), followed by a significant improvement of DE specification. In turn, DE cells developing from these cultures proceed with higher efficiency toward PF, PP, and EP cell lineages, as determined by a higher frequency of Sox9^+^Pdx1^+^ and Pdx1^+^Nkx6.1^+^ progenitors ([Figure 5](#fig5){ref-type="fig"}).

Although a role of Cx43 in the development and function of pancreatic islets has been previously analyzed in rodent and human pancreas ([@bib3], [@bib38], [@bib1]), our studies uncover the expression profile and function of this GJ protein during the early induction of DE cells and their downstream differentiation into PPs. Thus, whereas downregulation of Cx43 by RNA interference produced a significant reduction of DE cells developing from ESCs ([Figures 2](#fig2){ref-type="fig"}E and 2F), the functional activation of Cx43 by the AAP10 peptide resulted in the induction of FoxA2 and Sox17 genes ([Figures 4](#fig4){ref-type="fig"}A--4F), followed by a more efficient differentiation of ESCs into DE cells ([Figure 4](#fig4){ref-type="fig"}G). These results suggest that yet-to-be-identified signals exchanged through Cx43 GJ channels between differentiating ESCs must positively affect developmental decisions in ESCs. Our conclusions are also in agreement with those of previous studies showing that the combined genetic ablation of Cx43 and Cx45 in mouse ESC results in their failure to form primitive endoderm representing a key inductive stage for further differentiating into downstream cell lineages ([@bib32], [@bib50]), while other studies have also suggested an important dynamic modulation of Cx43 during hESC differentiation ([@bib14], [@bib36]).

The apparent normal development of pancreatic lineages in Cx43 mutant mice ([@bib3]) might be explained by possible species differences or compensatory functions contributed by other Cxs also expressed in the pancreas ([@bib39], [@bib38], [@bib1]).

Collectively, our results indicate that Cx43 GJ-mediated signaling events are important for a more efficient development of PP and EP cell lineages ([Figure 5](#fig5){ref-type="fig"}). Based on previous reports showing that Cx43 function is required for the expansion of the pancreatic islet cell mass ([@bib26]), our findings suggest that the function of this GJ protein may be dynamically regulated at distinct stages of ESC differentiation to encompass regulation of the cell cycle and promote the expansion of select cell lineages. This possibility is supported by the observation that Cx43 has been previously implicated in the regulation of EMT during the generation of human iPSCs ([@bib24]), and in mechanisms mediating the maintenance of stem cell pluripotency ([@bib8]). Collectively, these results provide significant experimental premise for the future design and identification of agonists that can selectively promote Cx-mediated cell-to-cell communication for a more efficient derivation of pancreatic islet cells.

Limitations of the Study {#sec3.1}
------------------------

Our studies took advantage of the validated properties of the AAP10 peptide that has been characterized as a potent activator of Cx43 function and that has been used clinically to promote the synchronization of cardiomyocytes and treat arrhythmias ([@bib48], [@bib6], [@bib21], [@bib10]). At present, although our results demonstrate an important role of Cx43 GJ function in the differentiation of ESCs into DE cells, and downstream cell lineages, it remains to be determined if enhancing intercellular communication mediated by other Cxs at subsequent stages of ESC differentiation may further improve yields of pancreatic islet cells from cultures of pluripotent stem cells. Based on the inherent difficulty in manipulating these mechanisms of cell communication, future studies will have to focus on the development of appropriate tools that allow the activation of other Cxs. Hence, based on our previous work demonstrating the importance of Cx36 in the development and function of human β-cells ([@bib38]), we anticipate that non-genetic gain-of-function approaches like the one used in this study will provide opportunities for testing the impact of activating cell-cell communication during processes of endocrine differentiation and maturation of progenitors into functional islet cells.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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